Interaction between different doses of simvastatin after two-week administration and metoprolol injection on the heart rate in normocholesterolemic rats

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 1, 2008, Pages 141-145

  Owczarek, Jacek ^a   Jasińska, Magdalena ^a   Orszulak Michalak, Daria ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Heart rate; Metoprolol; Rats; Simvastatin

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METOPROLOL; SIMVASTATIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; HEART RATE; MALE; NONHUMAN; RAT; WISTAR RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HEART RATE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INJECTIONS, INTRAPERITONEAL; MALE; METHYLCELLULOSE; METOPROLOL; RATS; RATS, WISTAR; SIMVASTATIN;

EID: 42549090998     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Maron D.J., Fazio S., Linton M.F.: Circulation 101, 207 (2000).
2. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study group: prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N. Engl. J. Med. 339, 1349 (1998).
3. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 8939 (1994).
4. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G. et al.: N. Engl. J. Med. 335, 1001 (1996).
5. Fonarow G.C., Wright R.S., Spencer F.A., Fredrick P.D., Dong W., Every N. et al.: Am. J. Cardiol. 96, 611 (2005).
6. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., MacFarlane P.W., et al.: N. Engl. J. Med. 333, 1301 (1995).
7. Jones S.P., Trocha S.D., Lefer D.J.: Arterioscler. Thromb. Vasc. Biol. 21, 2059 (2001).
8. Kaneider N.C., Reinisch C.M., Dunzendorfer S., Meierhofer C., Djanani A., Wiedermann C.J.: Atherosclerosis 158, 23 (2001).
9. Laufs U., Gertz K., Dirnagl U., Bohm M., Nickenig G., Endres M.: Brain Res. 28, 23 (2002).
10. Lefer A.M., Campbell B., Shin Y.K., Scalia R., Hayward R., Lefer D.J.: Circulation 100, 178 (1999).
11. Chen J., Shen H., Nagasawa Y., Mitsui K., Tsurugi K., Hashimoto K.: J. Pharmacol. Sci. 103, 317 (2007).
12. Mehta D., Curwin S., Gomes J.A., Fuster V.: Circ. 96, 3215 (1997).
13. Lucchesi B.R., Chi L., Friedrics G.S., Black S.C., Uprichard A.C.: Am. J. Cardiol. 72, 25F (1993).
14. Chen J., Nagasawa Y., Zhu B.M., Ohmori M., Harada K., Fujimura A., et al.: J. Pharmacol. Sci. 93, 87 (2003).
15. Pliquett U.R., Cornish G.K., Zucker I.H.: J. Appl. Physiol. 95, 700 (2003).
16. Philip J., Gentlesk M.D., Wiley T., Taylor A.J.: Am. Heart J. 150, 478 (2005).
17. Mühlhäuser U., Zolk O., Rau T., Münzel F., Wieland T., Eschenhagen T.: FASEB J. express article 10.1096/fj.05-5067fje. Published online February 8, 2006.
18. Chen Z.M., Pan H.C., Chen Y.P., Peto R., Collins R., Jiang L.X., Xie J.X., Liu L.S.: Lancet 366, 9497 (2005).
19. Siu S.W., Lau C.P., Tse H.F.: Am. J. Cardiol. 92, 1343 (2003).
20. Mitchell L.B., Powell J.L., Gillis A.M., Kehl V., Hallstrom A.P.: J. Am. Coll. Cardiol. 42, 81 (2003).
21. Wierzbicki A.S., Poston R., Ferro A.: Pharmacol. Ther. 99, 95 (2003).
22. Muntz K.H., Sternweis P.C., Gilman A.G., Mumby S.M.: Mol. Biol. Cell 3, 49 (1992).
23. Simonds W.F., Butrynski J.E., Gautam N., Unson C.G., Spiegel A.M.: J. Biol. Chem. 266, 5363 (1991).
24. Murga C., Esteban N., Ruiz-Gomez A., Mayor F. Jr.: FEBS Lett. 409, 24 (1997).
25. Node K., Fujita M., Kitakaze M., Hori M., Liao, J.K.: Circulation 108, 839 (2003).
26. Bountioukos M., Rizzello V., Krenning B.J., et al.: Am. J. Cardiol. 92, 613 (2003).